Charles Rivera: Unscripted

The Pestera II wind farm isn't just an energy project; it's a blueprint for attracting global capital and accelerating a national green transition.

As U.S. manufacturers race to modernize, a new report reveals a dangerous gap between innovation and security, turning consumer trust into a new battleground.

A curious cat, two discarded sliders, and a near-fatal poisoning. Roamin's story reveals the unseen dangers in our homes and the experts who save lives.

American Beacon and Aberdeen deepen their alliance with a new ETF, aiming to deliver tax-free income by actively navigating the complex municipal bond market.

A novel drug for glioblastoma enters a revolutionary trial, but the real story is the mission-driven company behind it, rewriting the rules of drug development.

International runners are turning Japan's marathons into extended family holidays, blending sport with cultural exploration and boosting local economies.

With M&A veterans Martin Babler and Troy Cox joining its board, MapLight Therapeutics is signaling a strategic shift from foundational research to late-stage execution.

Main Street Capital's $46.4M gain from Centre Technologies is more than a headline. It’s a masterclass in strategic partnership and lower middle market investment.

AM Best's 'Excellent' rating affirms Allshores' post-merger strength, but a closer look reveals a strategic battle against rising healthcare costs and climate risk.

A new digital portal and landmark law signal a pivotal shift in Saudi Arabia's Vision 2030, aiming to transform its economy beyond oil.

Avee Health’s milestone is a win for access, but it also signals a profound shift in public healthcare. We look at the why behind the virtual care boom.

A looming United Healthcare reimbursement change threatens to destabilize lactation care, leaving providers and new parents in a precarious position.

Clarevia Ventures' new partner isn't just another investor. She's a top analyst tasked with a critical mission: bridging the gap between science and patient impact.

A massive new solar and battery plant in rural Utah isn't just generating power; it's a blueprint for community investment and energy independence.

With Luna Federici as CEO, PicnicAI isn't just changing leaders; it's accelerating its mission to industrialize AI for health research and patient care.

As private credit swells to a $1.5 trillion industry, StoneCastle Securities appoints a veteran analyst to navigate its growing complexity and opportunity.

As the AIOps market matures, one company's recent analyst recognition highlights a crucial shift: moving from statistical AI to knowledge-based systems we can trust.

Access Vascular and Medline are betting on a new hydrogel catheter to cut costly complications. Can this blend of advanced biomaterials and scale change care?

A new partnership between AGEPHA Pharma and Close-Up Intl reveals how AI is not just a buzzword, but a critical tool for getting vital medicines to patients.

Tiffany Moon’s award celebrates compassion, but it also highlights a critical strategy for solving the home care crisis: investing in people.